Immuneering Corp (IMRX)
2.10
-0.01
(-0.47%)
USD |
NASDAQ |
Nov 22, 16:00
2.09
-0.01
(-0.48%)
After-Hours: 05:02
Immuneering Enterprise Value: 14.55M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 14.55M |
| November 21, 2024 | 14.86M |
| November 20, 2024 | 12.69M |
| November 19, 2024 | 12.69M |
| November 18, 2024 | 5.233M |
| November 15, 2024 | 5.233M |
| November 14, 2024 | 9.58M |
| November 13, 2024 | 2.438M |
| November 12, 2024 | 6.164M |
| November 11, 2024 | 8.338M |
| November 08, 2024 | 8.338M |
| November 07, 2024 | 9.270M |
| November 06, 2024 | 8.959M |
| November 05, 2024 | 10.20M |
| November 04, 2024 | 7.096M |
| November 01, 2024 | 7.406M |
| October 31, 2024 | 7.096M |
| October 30, 2024 | 8.959M |
| October 29, 2024 | 10.82M |
| October 28, 2024 | 15.79M |
| October 25, 2024 | 11.75M |
| October 24, 2024 | 16.10M |
| October 23, 2024 | 16.41M |
| October 22, 2024 | 17.65M |
| October 21, 2024 | 16.41M |
| Date | Value |
|---|---|
| October 18, 2024 | 18.90M |
| October 17, 2024 | 14.24M |
| October 16, 2024 | 18.27M |
| October 15, 2024 | 21.07M |
| October 14, 2024 | 11.44M |
| October 11, 2024 | 17.34M |
| October 10, 2024 | 18.27M |
| October 09, 2024 | 17.34M |
| October 08, 2024 | 23.55M |
| October 07, 2024 | 25.42M |
| October 04, 2024 | 26.04M |
| October 03, 2024 | 22.93M |
| October 02, 2024 | 24.79M |
| October 01, 2024 | 21.38M |
| September 30, 2024 | 26.66M |
| September 27, 2024 | 19.15M |
| September 26, 2024 | 17.67M |
| September 25, 2024 | 27.45M |
| September 24, 2024 | 26.86M |
| September 23, 2024 | 25.38M |
| September 20, 2024 | 35.46M |
| September 19, 2024 | 12.03M |
| September 18, 2024 | 7.881M |
| September 17, 2024 | 22.71M |
| September 16, 2024 | 25.38M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-35.13M
Minimum
May 25 2022
801.56M
Maximum
Sep 27 2021
133.09M
Average
80.31M
Median
Nov 14 2022
Enterprise Value Benchmarks
| Singular Genomics Systems Inc | -54.86M |
| Biomarin Pharmaceutical Inc | 11.91B |
| Integra Lifesciences Holdings Corp | 3.349B |
| Eton Pharmaceuticals Inc | 274.00M |
| AN2 Therapeutics Inc | -53.39M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -14.60M |
| Total Expenses (Quarterly) | 15.27M |
| EPS Diluted (Quarterly) | -0.49 |
| Earnings Yield | -93.81% |
| Normalized Earnings Yield | -91.43 |